Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP611661.RAbX337Z5l-hFGxeaiJ9k4W18R_oHnJNLz7v5W_xjx9YA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP611661.RAbX337Z5l-hFGxeaiJ9k4W18R_oHnJNLz7v5W_xjx9YA130_assertion type Assertion NP611661.RAbX337Z5l-hFGxeaiJ9k4W18R_oHnJNLz7v5W_xjx9YA130_head.
- NP611661.RAbX337Z5l-hFGxeaiJ9k4W18R_oHnJNLz7v5W_xjx9YA130_assertion description "[Immunohistochemistry was used to analyze samples of 40 newly diagnosed childhood acute lymphoblastic leukemias (ALL) for their expression of cyclins (D1, E, A), cyclin-dependent kinases (cdk2, cdk4) and tumor-suppressor genes (pRb, p16INK4A), in order to discover whether or not the expression of these various proteins may be of prognostic relevance for the survival of children with ALL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP611661.RAbX337Z5l-hFGxeaiJ9k4W18R_oHnJNLz7v5W_xjx9YA130_provenance.
- NP611661.RAbX337Z5l-hFGxeaiJ9k4W18R_oHnJNLz7v5W_xjx9YA130_assertion evidence source_evidence_literature NP611661.RAbX337Z5l-hFGxeaiJ9k4W18R_oHnJNLz7v5W_xjx9YA130_provenance.
- NP611661.RAbX337Z5l-hFGxeaiJ9k4W18R_oHnJNLz7v5W_xjx9YA130_assertion SIO_000772 9355972 NP611661.RAbX337Z5l-hFGxeaiJ9k4W18R_oHnJNLz7v5W_xjx9YA130_provenance.
- NP611661.RAbX337Z5l-hFGxeaiJ9k4W18R_oHnJNLz7v5W_xjx9YA130_assertion wasDerivedFrom befree-20150227 NP611661.RAbX337Z5l-hFGxeaiJ9k4W18R_oHnJNLz7v5W_xjx9YA130_provenance.
- NP611661.RAbX337Z5l-hFGxeaiJ9k4W18R_oHnJNLz7v5W_xjx9YA130_assertion wasGeneratedBy ECO_0000203 NP611661.RAbX337Z5l-hFGxeaiJ9k4W18R_oHnJNLz7v5W_xjx9YA130_provenance.